Fast science—with all its warts—is making unprecedented progress in the fight against COVID-19.

Download our poster of the biggest milestones, from the discovery of the viral family in humans in the 1960s to the identification of SARS-CoV-2.

Milder, cold-causing members of this pathogenic viral family long remained under the radar, although they aren’t entirely harmless.

Arbor Biosciences is offering free SARS-CoV-2 myBaits kits to all researchers.  

The viral protein known as ORF3b limits the induction of the type I interferon response, which typically alerts other immune system components to the presence of a virus, in cultured cells.

The abrupt termination comes after the research drew President Trump’s attention for its ties to the Wuhan Institute of Virology.

School shutdowns might have a relatively small effect on preventing the transmission of SARS-CoV-2, a new meta-analysis suggests, though the preliminary data point to the need for more studies.

There is little evidence that antihypertensive drugs worsen COVID-19, and scientists are instead exploring the idea that such medications—or their downstream effects—may actually alleviate symptoms.

The host transcriptional signature elicited by the coronavirus appears to be less robust and lacks the induction of key antiviral genes.